.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research offers a detailed look at localized synovial sarcoma outcomes through a multi-center retrospective analysis. Researchers assessed 248 patients treated between 2000 and 2024 at three US quaternary medical centers. Consequently, this study provides meaningful data on prognostic factors for clinicians managing this rare soft tissue malignancy. Notably, the median age at diagnosis was 35 years, reflecting the disease's tendency to affect young adults and adolescents.
The multivariable analysis revealed that tumor size and surgical margin status are the strongest predictors of survival. Specifically, larger tumors correlated with significantly worse disease-free survival. Moreover, patients with positive surgical margins faced a higher risk of recurrence. Although nearly 70% of patients received perioperative radiotherapy, its direct impact on overall survival in this cohort was not statistically significant in multivariable models. Similarly, chemotherapy did not show a definitive survival benefit for these specific patients. Therefore, surgical precision remains the cornerstone of effective management in synovial sarcoma.
Clinicians often use perioperative chemotherapy and radiotherapy to manage localized disease. In this study, 60% of patients underwent chemotherapy, while nearly 70% received radiotherapy. However, the data suggests that these treatments did not significantly alter the disease-free survival or overall survival when researchers adjusted for tumor size and margins. Furthermore, the median disease-free survival reached 110.3 months. In addition, the study recorded a median follow-up of 5.2 years, providing a robust window for observing long-term outcomes. Consequently, personalized treatment plans must prioritize achieving negative margins and monitoring high-risk tumor characteristics.
Tumor size and the adequacy of surgical margins are the primary factors influencing outcomes. Larger tumors and positive margins typically result in lower survival rates.
According to this study's multivariable analysis, perioperative chemotherapy did not provide a statistically significant survival benefit. However, clinicians often decide on chemotherapy based on individual risk factors and tumor size.
This study identified a median age of 35 years at diagnosis. This malignancy disproportionately affects young adults compared to other types of soft tissue sarcomas.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Testa S et al. A Multi-center Retrospective Outcomes Analysis of Patients with Localized Synovial Sarcoma. Cancer Res Commun. 2026 May 12. doi: 10.1158/2767-9764.CRC-25-0652. PMID: 42118560.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Soft Tissue Sarcoma. Version 3.2025.
Stacchiotti S, Van Tine BA. Synovial Sarcoma: Current Concepts and Future Perspectives. J Clin Oncol. 2018;36(2):180-187.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A multi-center analysis identifies tumor size and surgical margins as key predictors of survival in 248 patients with localized synovial sarcoma....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
